Oncology Institute (TOI) to Release Earnings on Tuesday

Oncology Institute (NASDAQ:TOIGet Free Report) is scheduled to be releasing its earnings data after the market closes on Tuesday, May 14th. Analysts expect Oncology Institute to post earnings of ($0.12) per share for the quarter. Oncology Institute has set its FY 2024 guidance at EPS.Persons that are interested in registering for the company’s earnings conference call can do so using this link.

Oncology Institute (NASDAQ:TOIGet Free Report) last issued its quarterly earnings data on Wednesday, March 27th. The company reported ($0.21) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.11) by ($0.10). Oncology Institute had a negative return on equity of 80.46% and a negative net margin of 24.56%. The business had revenue of $85.79 million for the quarter, compared to analysts’ expectations of $82.04 million. On average, analysts expect Oncology Institute to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Oncology Institute Stock Down 2.2 %

TOI stock opened at $0.93 on Monday. Oncology Institute has a one year low of $0.33 and a one year high of $2.66. The stock has a market capitalization of $69.11 million, a PE ratio of -1.01 and a beta of 0.82. The company has a debt-to-equity ratio of 1.52, a quick ratio of 3.73 and a current ratio of 4.12. The company has a fifty day moving average of $1.39 and a 200-day moving average of $1.73.

Analyst Ratings Changes

Separately, Jefferies Financial Group started coverage on shares of Oncology Institute in a research note on Monday, February 26th. They issued a “buy” rating and a $2.50 target price for the company.

Read Our Latest Stock Analysis on TOI

About Oncology Institute

(Get Free Report)

The Oncology Institute, Inc, an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services.

See Also

Earnings History for Oncology Institute (NASDAQ:TOI)

Receive News & Ratings for Oncology Institute Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncology Institute and related companies with MarketBeat.com's FREE daily email newsletter.